Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

计划入组 40 人 · 首次发布于 2026 年 7 月 2 日

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

计划入组 232 人 · 首次发布于 2018 年 11 月 14 日

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

计划入组 406 人 · 首次发布于 2017 年 12 月 12 日

TI-I-100

drug candidate

SRXXX (Epilepsy)

EPILEPSY FOUNDATION OF AMERICA

United States

Korean Epilepsy Society

South Korea

Redpharm Drug

United States

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil for Drug-Resistant Epilepsy

NIH Awards $2.8 Million Grant to Develop Next-Generation Brain Implant for Drug-Resistant Epilepsy

LivaNova's CORE-VNS Study Demonstrates Sustained Seizure Reduction in Drug-Resistant Epilepsy Patients